uses JavaScript to provide the best possible experience for our content, but your browser has it disabled. Learn how to enable it here.


Posted March 21, 2014

Products Containing Kratom Recalled Following FDA Import Alert

On March 14, 2014, SNI National issued a voluntary recall of all kratom supplements, including kratom XL 4 Pack, Maeng Da Kratom 10 Pack, Max Kratom 20 Pack, and Bali Kratom 40 pack, following an FDA-issued import alert on all products containing this ingredient.

Kratom (Mitragyna speciosa), also called mitragynine extract, biak-biak, cratom, gratom, ithang, kakuam, katawn, kedemba, ketum, krathom, krton, mambog, madat, Maeng da leaf, nauclea, Nauclea speciosa, or thang is a tree native to Southeast Asia. Supplements containing kratom typically contain powdered leaves or extract sold in powder, capsules or liquid, and are promoted for pain relief or energy.

Consumption of kratom has been associated with respiratory depression, nervousness, agitation, aggression, sleeplessness, hallucinations, delusions, tremors, loss of libido, constipation, skin hyperpigmentation, nausea, vomiting, and severe withdrawal symptoms.

Kratom products sold by SNI National are packaged in bright green clamshell, zip sealed packets and bottles containing 4, 10, 20 or 40 pills. They were sold to wholesale distributors in the following states: Alabama, California, Illinois, Missouri, Kentucky, Florida, Oklahoma, Idaho, Colorado, Wisconsin, Massachusetts, and Ohio.

Consumers who have purchased these supplements should discontinue use immediately and contact their healthcare provider if they have experienced any adverse side effects. Consumers and healthcare providers are also encouraged to report any adverse reactions to the FDA's MedWatch Adverse Event Reporting Program.

For more on this recall, use the link below.